Ludger Schöls Selected Research

Type 2 Episodic Ataxia

8/2021	Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.
1/2018	Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
4/2014	A novel missense mutation in CACNA1A evaluated by in silico protein modeling is associated with non-episodic spinocerebellar ataxia with slow progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludger Schöls Research Topics

Disease

33	Ataxia (Dyssynergia) 01/2022 - 02/2002
21	Hereditary Spastic Paraplegia 04/2022 - 04/2008
21	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022 - 10/2004
17	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 10/2004
12	Cerebellar Ataxia (Dysmetria) 12/2021 - 08/2006
10	Parkinson Disease (Parkinson's Disease) 06/2017 - 06/2002
9	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 03/2022 - 03/2002
8	Disease Progression 01/2022 - 10/2014
8	Friedreich Ataxia (Friedreich's Ataxia) 01/2021 - 04/2009
7	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 04/2009
5	Paraplegia (Spastic Paraplegia) 04/2022 - 05/2008
4	Neuroacanthocytosis 01/2020 - 04/2012
4	Multiple System Atrophy 01/2017 - 04/2011
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017 - 08/2012
3	Type 2 Episodic Ataxia 08/2021 - 04/2014
3	Cerebrotendinous Xanthomatosis 04/2021 - 11/2014
3	Seizures (Absence Seizure) 10/2020 - 05/2013
3	Parkinsonian Disorders (Parkinsonism) 01/2020 - 11/2015
3	Leukoencephalopathies 01/2020 - 10/2011
3	Dementia (Dementias) 06/2017 - 10/2014
3	Nervous System Diseases (Neurological Disorders) 01/2017 - 02/2007
2	Dysarthria (Spastic Dysarthria) 01/2022 - 11/2017
2	Neurodevelopmental Disorders 01/2022 - 01/2021
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2022 - 01/2021
2	Deglutition Disorders (Dysphagia) 12/2021 - 11/2017
2	Fatigue 08/2021 - 01/2017
2	Huntington Disease (Huntington's Disease) 01/2020 - 03/2015
2	Dystonia (Limb Dystonia) 01/2020 - 01/2019
2	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 01/2017
2	Chorea (Rheumatic Chorea) 01/2020 - 03/2015
2	Optic Nerve Diseases (Optic Neuropathy) 01/2020 - 08/2014
2	Brain Diseases (Brain Disorder) 01/2020 - 04/2015
2	Neoplasms (Cancer) 01/2018 - 01/2016
2	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 01/2018 - 10/2008
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 05/2016 - 03/2016
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2015 - 10/2014
2	Hereditary Diffuse Leukoencephalopathy with Spheroids 12/2014 - 12/2013
2	Paresis (Hemiparesis) 11/2014 - 04/2010
2	Muscle Spasticity (Spastic) 11/2014 - 04/2010
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 02/2014 - 12/2007
2	Apraxias (Dyspraxia) 10/2008 - 04/2008
2	Dystonic Disorders (Writer's Cramp) 11/2004 - 10/2004
1	Neuroinflammatory Diseases 01/2022
1	Spastic Paraplegia Type 4 01/2022

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2002
18	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2010
8	Ataxin-3IBA 05/2022 - 07/2006
8	polyglutamineIBA 03/2022 - 03/2002
6	EnzymesIBA 11/2021 - 11/2014
5	indium arsenide (InAs)IBA 09/2018 - 03/2012
5	alpha-SynucleinIBA 06/2017 - 09/2002
4	IronIBA 01/2022 - 03/2011
4	LithiumIBA 01/2020 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 04/2007
4	Biological ProductsIBA 02/2015 - 05/2013
3	Bile Acids and Salts (Bile Acids)IBA 04/2021 - 12/2019
3	LipidsIBA 01/2021 - 01/2018
3	NucleotidesIBA 08/2014 - 05/2008
3	Retinaldehyde (Retinal)IBA 01/2013 - 04/2011
2	sperm releasing substanceIBA 04/2022 - 11/2012
2	acetylleucineIBA 12/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2017
2	DNA Polymerase gammaIBA 11/2021 - 12/2012
2	Acetazolamide (Diamox)FDA LinkGeneric 08/2021 - 10/2011
2	4-Aminopyridine (4 Aminopyridine)FDA Link 08/2021 - 01/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 07/2021 - 10/2011
2	CholesterolIBA 04/2021 - 07/2011
2	protein kinase C gamma (PRKCG)IBA 01/2021 - 11/2005
2	Adenosine Triphosphatases (ATPase)IBA 01/2020 - 01/2020
2	Nonsense Codon (Nonsense Mutation)IBA 01/2020 - 04/2009
2	OxysterolsIBA 12/2019 - 01/2013
2	idebenoneIBA 06/2019 - 04/2009
2	Amino Acids FDA Link 01/2017 - 04/2014
2	Phosphotransferases (Kinase)IBA 01/2017 - 04/2012
2	AutoantibodiesIBA 01/2017 - 10/2014
2	Biocompatible Materials (Biomaterials)IBA 05/2016 - 04/2007
2	Cytochrome P450 Family 7IBA 01/2016 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 01/2016
2	Macrophage Colony-Stimulating FactorIBA 12/2014 - 12/2013
2	AntibodiesIBA 10/2014 - 03/2002
2	tributyl phosphate (TBP)IBA 09/2014 - 10/2004
2	KinesinsIBA 06/2014 - 05/2008
2	FrataxinIBA 06/2014 - 04/2009
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2008 - 04/2008
2	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2007 - 10/2004
1	teriflunomideIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022
1	Essential Amino AcidsIBA 12/2021
1	AcetylglucosamineIBA 11/2021
1	MonosaccharidesIBA 11/2021
1	Deubiquitinating EnzymesIBA 11/2021

Therapy/Procedure

6	Therapeutics 01/2022 - 02/2007
4	Activities of Daily Living (ADL) 01/2021 - 02/2015
2	Psychology Biofeedback (Biofeedback) 01/2022 - 01/2019
2	Enteral Nutrition (Feeding, Tube) 12/2021 - 10/2020
2	Transcranial Magnetic Stimulation 01/2018 - 02/2002
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2016
1	Speech Therapy (Therapy, Speech) 01/2022
1	Duration of Therapy 12/2021